Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6-1124P** is a pseudogene corresponding to a non-coding RNA segment that is similar in sequence to the functional U6 small nuclear RNA (snRNA), but is not itself transcribed into a functional product[4][5]. The U6 snRNA is an essential and highly conserved component of the spliceosome, playing a catalytic role in the removal of introns from pre-mRNA during splicing[1][3]. However, pseudogenes such as RNU6-1124P are generally regarded as non-functional due to mutations, truncations, or lack of necessary regulatory elements, and they do not produce active snRNAs or proteins[4][5]. These U6-derived pseudogenes are common in the human genome and reflect the evolutionary importance of the U6 snRNA gene and its sequence conservation, but their biological function—if any—is likely limited or absent, and they are not considered therapeutically actionable targets[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1124, pseudogene (RNU6-1124P).